What You Should Know:
– Vantive, a vital organ therapy company announced a significant global investment plan of more than US $1B over the next five years.
– The investment is earmarked for expanding research and development as well as production capacity, aimed at fueling the innovation of digitally-enabled therapies.
Addressing the Growing Burden of Kidney Disease and Acute Care Needs
The need for innovation in kidney care is urgent. Chronic kidney disease (CKD) is a widespread and costly condition, with annual expenditures in Europe alone estimated to exceed €140B. Factors such as aging populations and rising rates of diabetes and hypertension are driving an increase in the CKD patient population, intensifying pressure on global health systems. CKD is projected to become the fifth leading cause of death globally by 2040. Additionally, there’s a pressing need for acute organ support therapy options, as illustrated by the fact that as many as 60 percent of patients in intensive care units (ICU) may experience acute kidney injury.
Vantive’s investment aims to accelerate the pace of innovation in developing digitally-enabled dialysis and critical care products and services. The goal is to empower earlier and better-informed clinical decision-making, minimize care disruptions, shift kidney care management from reactive to proactive, enhance patient-care team connectivity, and expand access to more consistent, efficient, and personalized care.
“As we prepare to take part in our first ERA Congress as Vantive, we are proud to unveil this significant investment, which underscores our commitment to shaping the future of kidney care and vital organ support,” said Chris Toth, CEO of Vantive. “Better outcomes are possible when care is more accessible, more intuitive, and more connected to the needs of patients as well as the realities of the modern healthcare ecosystem. That’s why we are focused on transforming where and how therapy is delivered – from life-saving critical care for patients in a hospital, to life-sustaining dialysis for patients at home”.
